GSK3B and brain ischemia: It is well known that the PI3K/Akt/GSK-3β signaling pathway could be an important therapeutic target for neuroprotection against cerebral ischemia injury (Miyawaki et al., 2009; Lu et al., 2011; Dong et al., 2021).